U.S. Food and Drug Administration | MIDD Training Module 1 @US_FDA | Uploaded 2 months ago | Updated 4 hours ago
This lecture by Jeffrey Barrett from the Critical Path Institute describes the MIDD landscape for drug development and regulatory science, including background information describing model informed drug development in general, its context for use in the pharmaceutical industry, and the support from global regulatory authorities and an ever-expanding stakeholder community.
This module is part of the educational series “Model-Informed Drug Development (MIDD): Methods Advancing Medical Products to Patients”. The educational content was developed for regulatory scientists by experts in the field in partnership with the Critical Path Institute and funded by FDA CDER Office of Translational Sciences. As part of Multidisciplinary Education and Exchange initiatives, CDER’s Quantitative Medicine Center of Excellence is making this resource accessible to all, supporting community-wide educational enrichment.
Disclaimer: The presentations in this educational series reflect the views of the presenters and should not be construed to represent FDA’s views or policies.
This lecture by Jeffrey Barrett from the Critical Path Institute describes the MIDD landscape for drug development and regulatory science, including background information describing model informed drug development in general, its context for use in the pharmaceutical industry, and the support from global regulatory authorities and an ever-expanding stakeholder community.
This module is part of the educational series “Model-Informed Drug Development (MIDD): Methods Advancing Medical Products to Patients”. The educational content was developed for regulatory scientists by experts in the field in partnership with the Critical Path Institute and funded by FDA CDER Office of Translational Sciences. As part of Multidisciplinary Education and Exchange initiatives, CDER’s Quantitative Medicine Center of Excellence is making this resource accessible to all, supporting community-wide educational enrichment.
Disclaimer: The presentations in this educational series reflect the views of the presenters and should not be construed to represent FDA’s views or policies.
